Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
EMBO Molecular Medicine
|
January 12, 2013
TSC22D4 is a molecular output of hepatic wasting metabolism
Allan Jones, Kilian Friedrich, Maria Rohm, et al.
Nature Communications
|
June 8, 2019
Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells
Elizabeth Haythorne, Maria Rohm, Martijn van de Bunt, et al.
Nature Methods
|
April 22, 2024
Virtual reality-empowered deep-learning analysis of brain cells
Doris Kaltenecker, Rami Al-Maskari, Moritz Negwer, et al.
EMBO Molecular Medicine
|
March 10, 2022
Angpt2/Tie2 autostimulatory loop controls tumorigenesis
Ninelia Minaskan Karabid, Tobias Wiedemann, Sebastian Gulde, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 24, 2021
Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy
Pauline Morigny, Doris Kaltenecker, Julia Zuber, et al.
Nature Communications
|
April 22, 2026
TBL1X/TBL1XR1 govern β-cell identity through a PAX6-containing gene regulatory network
Alina A Walth-Hummel, Celine Jouffe, Peter Weber, et al.
Molecular Metabolism
|
April 4, 2020
'Corrigendum to "Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia" [Molecular Metabolism 5 (2) (2015) 67-78]'
Michaela Schäfer, Christian U Oeing, Maria Rohm, et al.
Molecular Metabolism
|
February 25, 2016
Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia
Michaela Schäfer, Christian U Oeing, Maria Rohm, et al.
Nature Medicine
|
August 30, 2016
An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice
Maria Rohm, Michaela Schäfer, Victor Laurent, et al.
Molecular Metabolism
|
June 10, 2026
Hepatokines lipocalin 2 and osteopontin drive muscle atrophy in MASH
Amy R Fumo, Simon I Dreher, Pauline Morigny, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
EMBO Molecular Medicine
|
January 12, 2013
TSC22D4 is a molecular output of hepatic wasting metabolism
Allan Jones, Kilian Friedrich, Maria Rohm, et al.
Nature Communications
|
June 8, 2019
Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells
Elizabeth Haythorne, Maria Rohm, Martijn van de Bunt, et al.
Nature Methods
|
April 22, 2024
Virtual reality-empowered deep-learning analysis of brain cells
Doris Kaltenecker, Rami Al-Maskari, Moritz Negwer, et al.
EMBO Molecular Medicine
|
March 10, 2022
Angpt2/Tie2 autostimulatory loop controls tumorigenesis
Ninelia Minaskan Karabid, Tobias Wiedemann, Sebastian Gulde, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
August 24, 2021
Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy
Pauline Morigny, Doris Kaltenecker, Julia Zuber, et al.
Nature Communications
|
April 22, 2026
TBL1X/TBL1XR1 govern β-cell identity through a PAX6-containing gene regulatory network
Alina A Walth-Hummel, Celine Jouffe, Peter Weber, et al.
Molecular Metabolism
|
April 4, 2020
'Corrigendum to "Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia" [Molecular Metabolism 5 (2) (2015) 67-78]'
Michaela Schäfer, Christian U Oeing, Maria Rohm, et al.
Molecular Metabolism
|
February 25, 2016
Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia
Michaela Schäfer, Christian U Oeing, Maria Rohm, et al.
Nature Medicine
|
August 30, 2016
An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice
Maria Rohm, Michaela Schäfer, Victor Laurent, et al.
Molecular Metabolism
|
June 10, 2026
Hepatokines lipocalin 2 and osteopontin drive muscle atrophy in MASH
Amy R Fumo, Simon I Dreher, Pauline Morigny, et al.
Page
of 5